Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation?

NCT06742333 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Bimekizumab
DRUG: Clobetasol

Sponsor

Centre Hospitalier Universitaire de Nice